Coeptis Therapeutics Holdings, Inc.
Develops cell therapy platforms for cancer, autoimmune, and infectious diseases.
COEP | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 105 BRADFORD ROAD, SUITE 420, 15090 WEXFORD
- Website:
- https://coeptistx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company developing innovative cell therapy platforms to treat cancer, autoimmune, and infectious diseases. The company's mission is to improve patient outcomes by addressing significant unmet medical needs. Its portfolio is centered on licensed technologies, including the SNAP-CAR platform, an adaptable cell therapy technology. Coeptis aims to advance novel therapeutic options through its commercial operations, which are conducted primarily via its subsidiary, Coeptis Pharmaceuticals, Inc.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Coeptis Therapeutics Holdings, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Coeptis Therapeutics Holdings, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Coeptis Therapeutics Holdings, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
